Selexis empowers scientists and biopharmaceutical companies around the world to realize the full potential of their work.

Who we are

Selexis SA is the global leader in mammalian cell line development, providing the highly specialized technology and expertise that are needed to translate scientific innovation into life-saving medicines.

SUREtechnology Platform

With more than 100 partners worldwide, 100+ drug products in clinical development and three commercial products utilizing Selexis-generated cell lines, the Company has a history of empowering scientists and biopharmaceutical companies around the world to realize the full potential of their research.

LOREM IPSUM

RECENT AND UPCOMING EVENTS

June 4 – 7, 2018
BIO International Convention, Boston, USA

June 27 – 29, 2018
BioPharma Expo Japan, Tokyo, Japan

October 10 – 12, 2018
Bio Japan, Yokahama, Japan

November 5 – 7, 2018
BIO Europe, Copenhagen, Denmark

November 5 – 8, 2018
JAACT 2018, Tsukuba, Japan

November 12-16, 2018
PEGS Summit Europe, Lisbon, Portugal



We are Social